ArticleKidney international reports2023

TRPC6 Inhibitor BI 764198 in Focal Segmental Glomerulosclerosis: Phase 2 Study Design.

Howard Trachtman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.